 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial |
| You-Bin Lee, Ki-Hyun Baek, Ho Yeon Chung, Dong-Won Byun, Yong-Ki Min |
|
jbm. 2022;29(3):155-163. Published online August 31, 2022 DOI: https://doi.org/10.11005/jbm.2022.29.3.155 |
|
Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial Journal of Bone Metabolism. 2022;29(3):155-163  Effect of multivitamin on serum 25-hydroxy vitamin D level in postmenopausal women: A randomized, double-blind, placebo-controlled trial Osteoporosis and Sarcopenia. 2016;2(2):89-93 Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6-Month Double-Blind Placebo-Controlled Trial Yearbook of Endocrinology. 2007;2007:336-337 Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia Journal of Bone and Mineral Metabolism. 2011;30(3):349-358 Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trial11Eli Lilly and Company (Indianapolis, IN) sponsored the Multiple Outcomes of Raloxifene Evaluation (MORE) trial. Bone. 2003;33(3):293-300 A randomized controlled trial: Comparison of total 25-hydroxy vitamin D level in premenopausal white women receiving vitamin D3 supplementation Journal of the American Academy of Dermatology. 2012;66(4):AB126 Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial Osteoporosis International. 2003;14(10):793-800 Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia) Clinical Interventions in Aging. 2014;1879 Comparison of 25-hydroxy vitamin D level in white women receiving vitamin D supplementation and not receiving supplementation: A randomized controlled trial Journal of the American Academy of Dermatology. 2012;66(4):AB174 Combination therapy with raloxifene and alendronate for treatment of osteoporosis in elderly women Maturitas. 2017;100:155 |
